Anti-Diabetogenic Properties of Mineralocorticoid Receptor Antagonists: Implications for Enhanced Safety and Efficacy of Post-Transplantation Pharmacotherapies. [electronic resource]
Producer: 20190429Description: 1102-1104 p. digitalISSN:- 1643-3750
- Calcineurin -- metabolism
- Calcineurin Inhibitors
- Cyclosporine
- Diabetes Complications -- drug therapy
- Diabetes Mellitus -- chemically induced
- Everolimus
- Graft Rejection -- drug therapy
- Humans
- Immunosuppressive Agents -- metabolism
- Kidney Transplantation
- Mineralocorticoid Receptor Antagonists -- pharmacology
- Sirolimus
- Spironolactone -- pharmacology
- Tacrolimus
- Transplantation Tolerance -- physiology
No physical items for this record
Publication Type: Editorial
There are no comments on this title.
Log in to your account to post a comment.